—

Kiniksa Pharmaceuticals Ltd (KNSA) — the peer cohort

As of 2026-11-09 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

Kiniksa Pharmaceuticals Ltd ranks 3 of 7 in its cohort on the Closelooknet composite (59/100) — the cohort is led by Laboratorios Farmaceuticos ROVI at 64/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
KNSA Kiniksa Pharmaceuticals Ltd 59 98 61 18 ok 0.6%
ROVI.MC Laboratorios Farmaceuticos ROVI 64 61 77 48 info 18.5%
LNTH Lantheus Holdings Inc 60 69 73 55 ok 9.7%
IRWD Ironwood Pharmaceuticals Inc 59 65 77 84 info 19%
GALDY GALDERMA GROUP AG 57 73 59 22 ok 2.4%
BHC.TO Bausch Health Companies Inc 55 91 50 85 ok 6.1%
FAGR.BR Fagron NV 55 68 56 58 info 2.6%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-11-09

Quick answers

Who are Kiniksa Pharmaceuticals Ltd's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: Laboratorios Farmaceuticos ROVI (ROVI.MC), Lantheus Holdings Inc (LNTH), Ironwood Pharmaceuticals Inc (IRWD), GALDERMA GROUP AG (GALDY), Bausch Health Companies Inc (BHC.TO), Fagron NV (FAGR.BR), as of 2026-11-09.

How does KNSA score against its peers?

Kiniksa Pharmaceuticals Ltd's composite reads 59/100, ranking 3 of 7 in its cohort as of 2026-11-09; the cohort's highest composite is Laboratorios Farmaceuticos ROVI at 64/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.